NEUROD1 and Alzheimer disease: This was successfully employed to drive expression of key proneural TFs for reprogramming, such as NeuroD1 and Dlx2, in mouse models of Alzheimer’s disease [15], Huntington’s disease [24], and ischemic brain injury [17].